TipRanks
Go Ultimate55% OFF

Ocumension Therapeutics (1477) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

1477 Analyst Ratings

Hold
1Ratings
0Buy1Hold0Sell
Based on 1 analysts giving stock ratings to Ocumension Therapeutics in the past 3 months

1477 Stock 12 Month Forecast

HKD 7.92â–²(65.34% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Ocumension Therapeutics in the last 3 months. The average price target is HKD 7.92 with a high forecast of HKD 7.92 and a low forecast of HKD 7.92. The average price target represents a 65.34% change from the last price of HKD 4.79.
Highest Price TargetHKD 7.92Average Price TargetHKD 7.92Lowest Price TargetHKD 7.92

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for HK:1477
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
Goldman Sachs Analyst forecast on HK:1477Unknown AnalystNot RankedGoldman SachsHKD 8.81→HKD 7.92hold65.34%UpsideReiterated09/02/26
CICC Analyst forecast on HK:1477Unknown AnalystNot RankedCICCHKD 10.16buy112.11%UpsideReiterated04/02/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1477 Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 1477
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy10000
Hold00011
Sell00000
Strong Sell00000
total10011

In the current month, 1477 has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1477 average Analyst price target in the past 3 months is 7.92.

1477 Financial Forecast

HKD -2HKD -1.25HKD -0.5HKD 0.25HKD 1Q2 2025Q2 2026Q4 2026
HighHKD 0.05
ConsensusHKD 0.05
LowHKD 0.05

1477 Earnings Forecast

Next quarter’s earnings estimate for 1477 is HKD 0.05 with a range of HKD 0.05 to HKD 0.05. The previous quarter’s EPS was -HKD 0.14. 1477 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1477 has Performed in-line its overall industry.

HKD 270.9MHKD 390.8MHKD 510.8MHKD 630.8MHKD 750.8MQ2 2025Q2 2026Q4 2026
HighHKD 751M
ConsensusHKD 751M
LowHKD 751M

1477 Sales Forecast

Next quarter’s sales forecast for 1477 is HKD 750.77M with a range of HKD 750.77M to HKD 750.77M. The previous quarter’s sales results were HKD 483.03M. 1477 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1477 has Performed in-line its overall industry.

1477 Stock Forecast FAQ

What is HK:1477’s average 12-month price target, according to analysts?
Based on analyst ratings, Ocumension Therapeutics’s 12-month average price target is HK$7.92.
What is HK:1477’s upside potential, based on the analysts’ average price target?
Ocumension Therapeutics has 65.34% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ocumension Therapeutics a Buy, Sell or Hold?
Ocumension Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Ocumension Therapeutics’s share price target?
The average share price target for Ocumension Therapeutics is HK$7.92. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$7.92, and the lowest forecast is HK$7.92. The average share price target represents a 65.34% increase from the current price of HK$4.79.
What do analysts say about Ocumension Therapeutics?
Ocumension Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Ocumension Therapeutics?
To buy shares of HK:1477, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.